Right-side and left-side colon cancer follow different pathways to relapse

Molecular Carcinogenesis

Volumn 51, Issue 5, 2012, Pages 411-421

  Bauer, Kerry M ^a   Hummon, Amanda B ^a   Buechler, Steven ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Colonic neoplasms; Disease free survival; Gene expression profiling

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TRANSCRIPTION FACTOR CDX2; WNT PROTEIN;

ARTICLE; ASCENDING COLON; CANCER CELL CULTURE; CANCER RELAPSE; CELL CYCLE REGULATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; DESCENDING COLON; FEMALE; GENETIC MARKER; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CELL CYCLE CHECKPOINTS; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MALE; NADPH OXIDASE; NEOPLASM STAGING; RECURRENCE; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEINS; WNT SIGNALING PATHWAY;

EID: 84859763945     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20804     Document Type: Article

References (32)

1. Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol 2008; 15: 2388-2394.
2. Benedix F, Kube R, Meyer F, et al. Comparison of 17, 641 patients with right- and left-sided colon cancer: Differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 2010; 53: 57-64.
3. Papagiorgis P, Oikonomakis I, Karapanagiotou I, Wexner SD, Nikiteas N. The impact of tumor location on the histopathologic expression of colorectal cancer. J BUON 2006; 11: 317-321.
4. Glebov OK, Rodriguez LM, Nakahara K, et al. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 2003; 12: 755-762.
5. Azzoni C, Bottarelli L, Campanini N, et al. Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: Arguments for different mechanisms in the tumorigenesis. Int J Colorectal Dis 2007; 22: 115-126.
6. Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004; 351: 2817-2826.
7. Van de Vijver MJ, He YD, van 't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999-2009.
8. Wang Y, Jatkoe T, Zhang Y, et al. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 2004; 22: 1564-1571.
9. Barrier A, Lemoine A, Boelle P-Y, et al. Colon cancer prognosis prediction by gene expression profiling. Oncogene 2005; 24: 6155-6164.
10. Webber EM, Lin JS, Whitlock EP. Oncotype DX tumor gene expression profiling in stage II colon cancer. Application: Prognostic, risk prediction. PLoS Curr 2010; 2.
11. Buechler S. Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer. BMC Cancer 2009; 9: 243.
12. Kamata T. Roles of Nox1 and other Nox isoforms in cancer development. Cancer Sci 2009; 100: 1382-1388.
13. Jorissen RN, Lipton L, Gibbs P, et al. DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers. Clin Cancer Res 2008; 14: 8061-8069.
14. Wu Z, Irizarry R, Gentleman R, Martinez-Murillo F. A model-based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc 2004; 99: 909-917.
15. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
16. Quasar Collaboration Group, Gray R, Barnwell J, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomised study. Lancet 2007; 370: 2020-2029.
17. Geiszt M, Lekstrom K, Brenner S, et al. NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes. J Immunol 2003; 171: 299-306.
18. Dexter DL, Spremulli EN, Fligiel Z, et al. Heterogeneity of cancer cells from a single human colon carcinoma. Am J Med 1981; 71: 949-956.
19. Liu XF, Olsson P, Wolfgang CD, et al. PRAC: A novel small nuclear protein that is specifically expressed in human prostate and colon. Prostate 2001; 47: 125-131.
20. Young J, Jass JR. The case for a genetic predisposition to serrated neoplasia in the colorectum: Hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev 2006; 15: 1778-1784.
21. Bleeker WA, Hayes VM, Karrenbeld A, et al. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer. Am J Gastroenterol 2000; 95: 2953-2957.
22. Hecker L, Vittal R, Jones T, et al. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 2009; 15: 1077-1081.
23. Mochizuki T, Furuta S, Mitsushita J, et al. Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene 2006; 25: 3699-3707.
24. Maranchie JK, Zhan Y. Nox4 is critical for hypoxia-inducible factor 2-alpha transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma. Cancer Res 2005; 65: 9190-9193.
25. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 2010; 141: 52-67.
26. Guo RJ, Suh ER, Lynch JP. The role of Cdx proteins in intestinal development and cancer. Cancer Biol Ther 2004; 3: 593-601.
27. Rozek LS, Lipkin SM, Fearon ER, et al. CDX2 polymorphisms, RNA expression, and risk of colorectal cancer. Cancer Res 2005; 65: 5488-5492.
28. Kawai H, Tomii K, Toyooka S, et al. Promoter methylation downregulates CDX2 expression in colorectal carcinomas. Oncol Rep 2005; 13: 547-551.
29. Guo RJ, Funakoshi S, Lee HH, Kong J, Lynch JP. The intestine-specific transcription factor Cdx2 inhibits beta-catenin/TCF transcriptional activity by disrupting the beta-catenin-TCF protein complex. Carcinogenesis 2010; 31: 159-166.
30. Funakoshi S, Kong J, Crissey MA, Dang L, Dang D, Lynch JP. Intestine-specific transcription factor Cdx2 induces E-cadherin function by enhancing the trafficking of E-cadherin to the cell membrane. Am J Physiol Gastrointest Liver Physiol 2010; 299: G1054-G1067.
31. Camps J, Armengol G, del Rey J, et al. Genome-wide differences between microsatellite stable and unstable colorectal tumors. Carcinogenesis 2006; 27: 419-428.
32. Lea IA, Jackson MA, Li X, Bailey S, Peddada SD, Dunnick JK. Genetic pathways and mutation profiles of human cancers: Site- and exposure-specific patterns. Carcinogenesis 2007; 28: 1851-1858.